| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
2020 12-31 |
2019 12-31 |
|---|---|---|---|---|---|---|---|
| Report Filing | 2025-11-19 | 2025-03-06 | 2024-03-07 | 2023-03-17 | 2022-03-24 | 2020-12-31 | 2019-12-31 |
| Revenue | 0.457 | 0.368 | 1.49 | 0.262 | 0 | 0 | 0.125 |
| Cost of Revenue | 0.329 | 0.536 | 1.22 | 0.792 | 0.086 | 0.159 | 0 |
| Gross Profit | 0.128 | -0.168 | 0.267 | -0.53 | -0.086 | -0.159 | 0.125 |
| Operating Expenses | 24.8 | 22.66 | 23.61 | 18.87 | 9.31 | 8.21 | 9.69 |
| Research & Development | 11.44 | 11.26 | 12.72 | 9.48 | 4.99 | 5.12 | 5.71 |
| Selling, General and Administrative | 13.36 | 11.4 | 10.89 | 9.39 | 4.41 | 3.09 | 3.98 |
| Other Operating Expenses | 0 | 0 | 0 | 0 | -0.086 | 0 | 0 |
| Operating Income | -24.68 | -22.83 | -23.35 | -19.4 | -9.4 | -8.37 | -9.57 |
| Net Non-Operating Interest | -1.54 | -1.12 | 0.138 | 0.044 | 0 | 0.04 | 0.231 |
| Interest Income | 0.075 | 0 | 0.138 | 0.044 | 0.01 | 0.04 | 0.231 |
| Interest Expense | 1.61 | 1.12 | 0 | 0 | 0.01 | 0 | 0 |
| Equity & Other Income/(Expense) | -7.3 | -5.31 | 0.397 | 0.12 | 1.6 | -0.005 | 0 |
| Income Before Tax | -33.52 | -29.25 | -22.81 | -19.24 | -7.8 | -8.34 | -9.34 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -33.52 | -29.25 | -22.81 | -19.24 | -7.8 | -8.34 | -9.34 |
| Depreciation and Amortization | 0.867 | 0.669 | 0.931 | 0.605 | 0.086 | 0.159 | 0.159 |
| EBITDA | -23.81 | -22.16 | -22.41 | -18.8 | -9.31 | -8.21 | -9.41 |
| Earnings Per Share (EPS) | -16.59 | -22.13 | -51.86 | -55.04 | -121 | -798.4 | -902 |
| Diluted Earnings Per Share | -16.59 | -22.13 | -51.86 | -55.04 | -121 | -798.4 | -902 |
| Weighted Average Shares Outstanding | 7.04 | 1.32 | 0.44 | 0.349 | 0.064 | 0.01 | 0.01 |
| Diluted Weighted Average Shares Outstanding | 7.04 | 1.32 | 0.44 | 0.349 | 0.064 | 0.01 | 0.01 |
